Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Aethlon Medical, Inc. (AEMD)

0.3506   -0.006 (-1.6%) 06-09 13:58
Open: 0.3563 Pre. Close: 0.3563
High: 0.3564 Low: 0.3403
Volume: 77,417 Market Cap: 8(M)

Technical analysis

as of: 2023-06-09 2:13:06 PM
Short-term rate:       
Stoxline posted a BUY today, same as yesterday. Upward movement continues.
Mid-term rate:       
Target: Six months: 0.43     One year: 0.5
Support: Support1: 0.32    Support2: 0.28
Resistance: Resistance1: 0.37    Resistance2: 0.43
Pivot: 0.32
Moving Average: MA(5): 0.34     MA(20): 0.32
MA(100): 0.42     MA(250): 0.63
MACD: MACD(12,26): -0.1     Signal(9): -0.1
Stochastic oscillator: %K(14,3): 72.1     %D(3): 73
RSI: RSI(14): 53.3
52-week: High: 2.46  Low: 0.23
Average Vol(K): 3-Month: 921 (K)  10-Days: 177 (K)

Price, moving averages and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
[ AEMD ] has closed below upper band by 8.5%. Bollinger Bands are 61% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 17 bars. This is a sign that the market may be about to initiate a new trend.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 0.36 - 0.36 0.36 - 0.36
Low: 0.33 - 0.34 0.34 - 0.34
Close: 0.34 - 0.34 0.34 - 0.35

Company Description

Aethlon Medical, Inc., a medical technology company, focuses on developing products to diagnose and treat life and organ threatening diseases in the United States. The company develops Aethlon Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses from the human circulatory system, including removal of COVID-19 virus, associated variants, and related exosomes. Aethlon Medical, Inc. has a collaboration with the University of Pittsburgh Medical Center Hillman Cancer Center for studies related to head and neck cancer. The company was founded in 1999 and is based in San Diego, California.

Headline News

Wed, 07 Jun 2023
Aethlon Medical : June 2023 LD Micro Presentation | MarketScreener -

Mon, 22 May 2023
Aethlon Medical Receives Ethics Board Approval to Add Second ... - PR Newswire

Mon, 24 Apr 2023
5 Hot Penny Stocks To Watch With The Stock Market Down This Week - Penny Stocks

Thu, 20 Apr 2023
Why Nevro Shares Are Trading Lower By Around 19%? Here Are Other Stocks Moving In Thursday’s Mid-Day Sess - Benzinga

Wed, 15 Feb 2023
AEMD: New CRO to Help Advance Studies; Expanded Team to Facilitate Efforts - Yahoo Finance

Mon, 13 Feb 2023
Aethlon Medical Announces Third Quarter Financial Results and ... - PR Newswire

Financial Analysis

Price to Book Value: Neutral
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Underperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Underperform
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Underperform
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Neutral
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Medical Devices
Shares Out. 0 (M)
Shares Float 23 (M)
% Held by Insiders 2.274e+007 (%)
% Held by Institutions 1 (%)
Shares Short 131 (K)
Shares Short P.Month 0 (K)

Stock Financials

EPS -1.302e+007
EPS Est Next Qtl 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0
Profit Margin (%) 0
Operating Margin (%) -100
Return on Assets (ttm) 689.4
Return on Equity (ttm) -38.8
Qtrly Rev. Growth 13120
Gross Profit (p.s.) 0
Sales Per Share -59.8
EBITDA (p.s.) 249297
Qtrly Earnings Growth -0.8
Operating Cash Flow 0 (M)
Levered Free Cash Flow -11 (M)

Stock Valuations

PE Ratio -0.01
PEG Ratio 0
Price to Book value 0
Price to Sales -0.01
Price to Cash Flow 0.55

Stock Dividends

Dividend 0
Forward Dividend 120930
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Your Ad Here
StockChart iOS
StoxlineLite iOS
StoxlineLite iOS
OptionCalc iOS
StockChart Android
StoxlineLite Android
StoxlinePro Android
OptionCalc Android
(c) 2006-2022 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.